Biomarkers for Precision Psychiatry
We’re pioneering blood biomarkers and artificial intelligence to deliver scalable diagnostics and breakthrough therapies for mental illness.
The first mental health biomarker database of its kind.
We believe the future of mental health care lies in precision medicine, and we’re leading the way by building the world’s first integrated biomarker database for psychiatric disorders.
By combining deep blood biomarker profiling with comprehensive clinical data, we leverage cutting-edge AI to decode complex biological patterns. This approach accelerates treatment discovery, de-risks clinical trials, and fast-tracks diagnostics—ensuring patients receive safer, more effective therapies faster than ever before.
Patient Data
Ketim Therapeutics works and partners with hospitals, and research centres to curate, enrich and generate patient-rich data for biomarker discovery.
Biomarker Discovery
We identify blood biomarkers linked to psychiatric disorders using advanced molecular profiling technology with high analytical sensitivity and accuracy.
Proprietary Database
Using AI and machine learning, we curate and integrate the biomarker data, psychiatric rating scales, and the full clinical and social factors to enable personalized mental illness insights.
At the forefront of scientific discovery, our biotech company pioneers breakthroughs that redefine possibilities in mental health. By harnessing cutting-edge technology and AI, we are committed to transforming lives and shaping a better future for families and generations to come.
We are starting with perinatal mental health.
The Problem
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can aid in objectively diagnosing patients and providing individualized treatment recommendations.
Integration of biomarkers, clinical data and full patient history for each individual is compounded - this leads to subjective biases and a high rate of under- and mis-diagnoses in mental health.
Our Solution
Ketim Therapeutics is focused on changing the paradigm of psychiatric-care, by building and easing access to big data and molecular biomarkers through a curated database to impact better and faster treatments.
What makes our pipeline different?
Powered by deep biomarker profiling and multimodal patient data, our AI uncovers novel targets and matches them to the right patient subgroups for more precise treatments. By seamlessly integrating wet lab validation with advanced AI analytics, we create a continuous feedback loop that refines discoveries and accelerates breakthroughs in psychiatric care.
“Having experienced postnatal depression myself, my lived experience fuels my passion to support other mothers during a time when help can feel out of reach.
My vision is to combine my personal journey with my deep expertise in psychiatric biomarkers to usher in a new era of personalized mental health care”
- Dr Clarissa Yates, CEO of Ketim Therapeutics